RegeNephron, a spinout of Kyoto University’s Center for iPS Cell Research and Application (CiRA), said on September 9 that it has sealed a collaborative research accord with Kirin Holdings for process development related to cell therapies using nephron progenitor cells.…
To read the full story
Related Article
- Kyoto Univ. Spinout Boots Up to Develop iPSC-Based Kidney Therapy
September 24, 2019
BUSINESS
- Japan Clears Fujirebio’s Blood-Based Aβ42 Test for Alzheimer’s
November 19, 2026
- Sobi Japan to Take Over Orfadin from Astellas in December
November 19, 2026
- Shionogi Closes US$2 Billion IntraBio Buyout, Gains Rare Disease Drug
November 19, 2026
- AbbVie Japan Launches Skyrizi 55 mg for Pediatric Psoriasis
November 19, 2026
- Japan Drug Makers’ H1 Sales Surge 14.7% as Weak Yen Fuels Growth
November 18, 2026
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…





